OBJECTIVES: The aim of the study was to assess the expression of the Rb pathway (p16(INK4a)-cdk4-pRb) in cervical intraepithelial neoplasia as a prognostic marker by investigating the association between expression of Rb pathway and the recurrence. METHODS: The study group comprised of 265 paraffin-embedded tissues of the uterine cervix collected from patients between 2001 and 2003. Patients underwent ablative or excisional treatment and were followed for 2 years. RB pathway expression was examined using immunohistochemistry applied to a tissue microarray. HPV detection and genotyping were performed with HPV DNA Chip. Statistical analysis was done by ANOVA test, Student's t test, and Pearson's correlation test. RESULTS: With increasing CIN grade, p16(INK4a) and cdk4 expression rates increased, while the pRb expression rate decreased. The expression rate of p16(INK4a) was higher (33%) in CIN I with high-risk HPV infection than in CIN I without high-risk HPV infection (19%). The mean expression rates of p16(INK4a) were 29%, 39%, and 64%, respectively, in CIN I, II, and III without recurrence, but 25%, 28%, and 44% in those with recurrence. The mean expression rates of pRb were 47%, 40%, and 18% in CIN I, II, and III without recurrence, respectively, but 48%, 45%, and 34% in those with recurrence. CONCLUSION: A relatively low expression rate of p16(INK4a) has prognostic significance for predicting recurrence. The clinical utility of p16(INK4a) status for stratifying patients according to their need for aggressive treatment requires further investigation.
OBJECTIVES: The aim of the study was to assess the expression of the Rb pathway (p16(INK4a)-cdk4-pRb) in cervical intraepithelial neoplasia as a prognostic marker by investigating the association between expression of Rb pathway and the recurrence. METHODS: The study group comprised of 265 paraffin-embedded tissues of the uterine cervix collected from patients between 2001 and 2003. Patients underwent ablative or excisional treatment and were followed for 2 years. RB pathway expression was examined using immunohistochemistry applied to a tissue microarray. HPV detection and genotyping were performed with HPV DNA Chip. Statistical analysis was done by ANOVA test, Student's t test, and Pearson's correlation test. RESULTS: With increasing CIN grade, p16(INK4a) and cdk4 expression rates increased, while the pRb expression rate decreased. The expression rate of p16(INK4a) was higher (33%) in CIN I with high-risk HPV infection than in CIN I without high-risk HPV infection (19%). The mean expression rates of p16(INK4a) were 29%, 39%, and 64%, respectively, in CIN I, II, and III without recurrence, but 25%, 28%, and 44% in those with recurrence. The mean expression rates of pRb were 47%, 40%, and 18% in CIN I, II, and III without recurrence, respectively, but 48%, 45%, and 34% in those with recurrence. CONCLUSION: A relatively low expression rate of p16(INK4a) has prognostic significance for predicting recurrence. The clinical utility of p16(INK4a) status for stratifying patients according to their need for aggressive treatment requires further investigation.
Authors: I L Bergin; J D Bell; Z Chen; M K Zochowski; D Chai; K Schmidt; D L Culmer; D M Aronoff; D L Patton; J M Mwenda; C E Wood; R D Burk Journal: Vet Pathol Date: 2012-03-23 Impact factor: 2.221
Authors: Anjelica Hodgson; Kay J Park; Bojana Djordjevic; Brooke E Howitt; Marisa R Nucci; Esther Oliva; Simona Stolnicu; Bin Xu; Robert A Soslow; Carlos Parra-Herran Journal: Am J Surg Pathol Date: 2019-01 Impact factor: 6.394
Authors: I Tsoumpou; M Arbyn; M Kyrgiou; N Wentzensen; G Koliopoulos; P Martin-Hirsch; V Malamou-Mitsi; E Paraskevaidis Journal: Cancer Treat Rev Date: 2009-03-03 Impact factor: 12.111
Authors: Eun Ji Nam; Jae Wook Kim; Jong Wook Hong; Hyoung Sun Jang; Sang Yub Lee; Si Young Jang; Dae Woo Lee; Sang Wun Kim; Jae Hoon Kim; Young Tae Kim; Sunghoon Kim; Jong Wook Kim Journal: J Gynecol Oncol Date: 2008-09-30 Impact factor: 4.401
Authors: Marilia Freitas Calmon; Mânlio Tasso de Oliveira Mota; Érica Babeto; Natália Maria Candido; Ana Paula Girol; Carlos Fabian Mendiburu; Jane Lopes Bonilha; Rodrigo Vellasco Duarte Silvestre; Bruno Miziara Rosa; Jorge Alberto Thomé; Gustavo Hernandez Américo Medeiros; Fernando Augusto Soares; Gustavo Cardoso Guimarães; José Germano Ferraz de Arruda; Sonia Maria Oliani; Luisa Lina Villa; José Vassallo; Paula Rahal Journal: PLoS One Date: 2013-01-14 Impact factor: 3.240
Authors: Alcina F Nicol; Andréa Rodrigues Cordovil Pires; Simone R de Souza; Gerard J Nuovo; Beatriz Grinsztejn; Aparecida Tristão; Fabio B Russomano; Luciane Velasque; José R Lapa e Silva; Claude Pirmez Journal: BMC Cancer Date: 2008-10-07 Impact factor: 4.430